Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.1B
Enterprise Value5.81B
P/E Ratio-17.22
PEG Ratio-0.21
Price/Sales Ratio1.96
Price/Book Ratio3.81
Enterprise/Revenue2.29
Enterprise/EBITDA-50.36

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.11
Operating Margin-0.09
AD

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.22

Income Statement

Revenue2.27B
Revenue/Share2.05
Gross Profit1.13B
EBITDA-29.17M
Net Income-288.58M
Diluted EPS-0.27

Balance Sheet

Total Cash1.13B
Total Cash/Share1.04
Total Debt1.53B
Total Debt/Equity1.33
Current Ratio0.81
Book Value Per Share1.11

Price History

52-Week Change-27.31
52-Week High5.82
52-Week Low3.7
Moving Average 50 Days4.53
Moving Average 200 Days4.74

Statistics

Average Volume27.58M
Shares Outstanding1.09B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.17
Last Split Factor17:10
Last Split DateSeptember 23, 2019
AD